A few days ago, a new use of Zyprexa (olanzapine), manufactured by Eli Lilly, was approved in the US - for bipolar affective disorder (BPAD). It is believed to delay relapses (regardless of the nature of the current episode).
Ad:
Panthermedia
Tablets